{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:00:44Z","timestamp":1789747244957,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Zhejiang Medical Association Clinical Research Fund","award":["2013ZYC-A144"],"award-info":[{"award-number":["2013ZYC-A144"]}]},{"name":"Taizhou Science and Technology Plan","award":["1301ky55"],"award-info":[{"award-number":["1301ky55"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.bbrc.2015.06.103","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T13:15:17Z","timestamp":1434633317000},"page":"407-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2"],"prefix":"10.1016","volume":"464","author":[{"given":"Zejun","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoju","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3308-1014","authenticated-orcid":false,"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingming","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mintao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuchai","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.06.103_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2015.06.103_bib2","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1158\/1055-9965.EPI-09-0090","article-title":"International trends in colorectal cancer incidence rates","volume":"18","author":"Center","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.bbrc.2015.06.103_bib3","first-page":"2755","volume":"23","author":"Guo","year":"2012","journal-title":"Trends in cancer mortality in China: an update. Ann. Oncol."},{"key":"10.1016\/j.bbrc.2015.06.103_bib4","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"Ferlay","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.103_bib5","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/annonc\/mds024","article-title":"European cancer mortality predictions for the year 2012","volume":"23","author":"Malvezzi","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbrc.2015.06.103_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1146\/annurev.biochem.75.103004.142443","article-title":"Ribonucleotide reductases","volume":"75","author":"Nordlund","year":"2006","journal-title":"Annu Rev. Biochem."},{"key":"10.1016\/j.bbrc.2015.06.103_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/35003506","article-title":"A\u00a0ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage","volume":"404","author":"Tanaka","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2015.06.103_bib8","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/sj.onc.1206232","article-title":"RRM1-induced metastasis suppression through PTEN-regulated pathways","volume":"22","author":"Gautam","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2015.06.103_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s13277-015-3137-4","article-title":"Non-enzymatic action of RRM1 protein upregulates PTEN leading to inhibition of colorectal cancer metastasis","author":"Qi","year":"2015","journal-title":"Tumour Biol."},{"key":"10.1016\/j.bbrc.2015.06.103_bib10","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.humpath.2010.06.001","article-title":"Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in\u00a0vitro","volume":"41","author":"Morikawa","year":"2010","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbrc.2015.06.103_bib11","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/bjc.2013.817","article-title":"Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer","volume":"110","author":"Wang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.103_bib12","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.3892\/ijo.2015.2912","article-title":"Ribonucleotide reductase M2 is a promising molecular target for the treatment of oral squamous cell carcinoma","volume":"46","author":"Iwamoto","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2015.06.103_bib13","first-page":"1650","article-title":"The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation","volume":"58","author":"Fan","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2015.06.103_bib14","doi-asserted-by":"crossref","first-page":"14036","DOI":"10.1073\/pnas.93.24.14036","article-title":"Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential","volume":"93","author":"Fan","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.06.103_bib15","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2006.12.177","article-title":"RRM2 induces NF-kappaB-dependent MMP-9 activation and enhances cellular invasiveness","volume":"354","author":"Duxbury","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2015.06.103_bib16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-4598-8-11","article-title":"Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in\u00a0vitro and in\u00a0vivo: implication of RRM2 in angiogenesis","volume":"8","author":"Zhang","year":"2009","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.103_bib17","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/ijc.24559","article-title":"E2F4 and ribonucleotide reductase mediate S-phase arrest in colon cancer cells treated with chlorophyllin","volume":"125","author":"Chimploy","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.103_bib18","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1093\/carcin\/bgu124","article-title":"Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells","volume":"35","author":"Lai","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbrc.2015.06.103_bib19","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1128\/MCB.17.9.5508","article-title":"Induction of S-phase entry by E2F transcription factors depends on their nuclear localization","volume":"17","author":"Muller","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2015.06.103_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/(SICI)1097-0215(19990517)81:4<535::AID-IJC5>3.0.CO;2-4","article-title":"Expression of the E2F family in human gastrointestinal carcinomas","volume":"81","author":"Suzuki","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2015.06.103_bib21","first-page":"2365","article-title":"Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylate synthase","volume":"60","author":"Banerjee","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2015.06.103_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000028069","article-title":"Expression of cell-cycle-regulating transcription factor E2F-1 in colorectal carcinomas","volume":"67","author":"Yasui","year":"1999","journal-title":"Pathobiology"},{"key":"10.1016\/j.bbrc.2015.06.103_bib23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0006-2952(02)01264-9","article-title":"SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells","volume":"64","author":"Yu","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2015.06.103_bib24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/CS20120240","article-title":"Ribonucleotide reductase small subunit M2 serves as a prognostic biomarker and predicts poor survival of colorectal cancers","volume":"124","author":"Liu","year":"2013","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbrc.2015.06.103_bib25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3816\/CCC.2007.n.007","article-title":"Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancer","volume":"6","author":"Liu","year":"2007","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.bbrc.2015.06.103_bib26","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1158\/1078-0432.CCR-06-0799","article-title":"Metastasis-suppressing potential of ribonucleotide reductase small subunit p53R2 in human cancer cells","volume":"12","author":"Liu","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2015.06.103_bib27","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1016\/S0021-9258(17)39337-7","article-title":"Cell cycle-dependent expression of mammalian ribonucleotide reductase. Differential regulation of the two subunits","volume":"260","author":"Engstrom","year":"1985","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.06.103_bib28","first-page":"5151","article-title":"Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation","volume":"48","author":"Mann","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2015.06.103_bib29","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/MCB.15.8.4215","article-title":"Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1\/S-regulatory genes","volume":"15","author":"DeGregori","year":"1995","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2015.06.103_bib30","doi-asserted-by":"crossref","first-page":"10796","DOI":"10.1074\/jbc.M312482200","article-title":"S\u00a0Phase-specific transcription of the mouse ribonucleotide reductase R2 gene requires both a proximal repressive E2F-binding site and an upstream promoter activating region","volume":"279","author":"Chabes","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.06.103_bib31","doi-asserted-by":"crossref","first-page":"18085","DOI":"10.1074\/jbc.M109.003020","article-title":"Implication of checkpoint kinase-dependent up-regulation of ribonucleotide reductase R2 in DNA damage response","volume":"284","author":"Zhang","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.06.103_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/35106593","article-title":"The E2F1-3 transcription factors are essential for cellular proliferation","volume":"414","author":"Wu","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2015.06.103_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/ncb974","article-title":"Chk2 activates E2F-1 in response to DNA damage","volume":"5","author":"Stevens","year":"2003","journal-title":"Nat. Cell Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15301571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15301571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T00:43:30Z","timestamp":1652489010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15301571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0006291X15301571"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.103","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.06.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}